SC 13G/A | 2024-08-14 | Rosalind Advisors, Inc. | Cellectar Biosciences, Inc. | 3,671,550 | 9.9% | EDGAR |
SC 13G/A | 2024-07-11 | Rosalind Advisors, Inc. | Cellectar Biosciences, Inc. | 2,709,516 | 9.9% | EDGAR |
SC 13G/A | 2024-04-25 | Rosalind Advisors, Inc. | Cellectar Biosciences, Inc. | 3,305,936 | 9.9% | EDGAR |
SC 13G/A | 2024-02-14 | LYTTON LAURENCE W | Cellectar Biosciences, Inc. | 3,280,178 | 10.0% | EDGAR |
SC 13G/A | 2024-02-14 | Lincoln Park Capital Fund, LLC | Cellectar Biosciences, Inc. | 1,307,049 | 9.7% | EDGAR |
SC 13G/A | 2024-02-14 | Rosalind Advisors, Inc. | Cellectar Biosciences, Inc. | 1,488,400 | 9.9% | EDGAR |
SC 13G | 2024-02-14 | Nantahala Capital Management, LLC | Cellectar Biosciences, Inc. | 3,229,903 | 9.9% | EDGAR |
SC 13G/A | 2024-02-07 | HIRSCHMAN ORIN | Cellectar Biosciences, Inc. | 2,662,324 | 8.7% | EDGAR |
SC 13G | 2024-01-31 | ADAR1 Partners, LP | Cellectar Biosciences, Inc. | 1,824,063 | 6.2% | EDGAR |
SC 13G | 2023-12-07 | LYTTON LAURENCE W | Cellectar Biosciences, Inc. | 1,885,073 | 10.0% | EDGAR |
SC 13G | 2023-12-05 | HIRSCHMAN ORIN | Cellectar Biosciences, Inc. | 1,915,220 | 9.9% | EDGAR |
SC 13G/A | 2023-02-14 | Rosalind Advisors, Inc. | Cellectar Biosciences, Inc. | 986,293 | 9.9% | EDGAR |
SC 13G/A | 2023-02-13 | LYTTON LAURENCE W | Cellectar Biosciences, Inc. | 482,430 | 5.0% | EDGAR |
SC 13G/A | 2022-11-03 | Rosalind Advisors, Inc. | Cellectar Biosciences, Inc. | 605,228 | 9.9% | EDGAR |
SC 13G | 2022-10-25 | Lincoln Park Capital Fund, LLC | Cellectar Biosciences, Inc. | 937,588 | 10.0% | EDGAR |
SC 13G/A | 2022-02-15 | LYTTON LAURENCE W | Cellectar Biosciences, Inc. | 4,177,792 | 6.6% | EDGAR |
SC 13G/A | 2022-02-14 | Consonance Capital Management LP | Cellectar Biosciences, Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2022-02-10 | Sio Capital Management, LLC | Cellectar Biosciences, Inc. | - | 0.0% | EDGAR |
SC 13G/A | 2022-01-21 | Rosalind Advisors, Inc. | Cellectar Biosciences, Inc. | 6,052,282 | 9.9% | EDGAR |
SC 13G | 2021-07-08 | Rosalind Advisors, Inc. | Cellectar Biosciences, Inc. | 3,207,160 | 6.0% | EDGAR |